Cargando…
Tumoral indoleamine 2, 3-dioxygenase 1 is regulated by monocytes and T lymphocytes collaboration in hepatocellular carcinoma
Indoleamine 2, 3-Dioxygenase 1 (IDO1) in cancer cells plays a critical role in tumor immunosuppression. However, the precise mechanisms regulating tumoral IDO1 expression in tumor milieus remain unclear. Here, we reported that IDO1 expression in tumor cells of hepatocelluar carcinomas (HCC), display...
Autores principales: | Zhao, Qiyi, Wang, Pei-pei, Huang, Zhan-lian, Peng, Liang, Lin, Chaoshuang, Gao, Zhiliang, Su, Shicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924751/ https://www.ncbi.nlm.nih.gov/pubmed/26895379 http://dx.doi.org/10.18632/oncotarget.7438 |
Ejemplares similares
-
Mechanism and prognostic value of indoleamine 2,3‐dioxygenase 1 expressed in hepatocellular carcinoma
por: Li, Shaolong, et al.
Publicado: (2018) -
Expression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes
por: Liu, Peng, et al.
Publicado: (2009) -
Laeverin/aminopeptidase Q induces indoleamine 2,3-dioxygenase-1 in human monocytes
por: Suzuki, Takuma, et al.
Publicado: (2023) -
Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
por: Asghar, Kashif, et al.
Publicado: (2017) -
Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
por: Peng, Xuerun, et al.
Publicado: (2022)